FDA Maintains Miniscule Melamine Levels Pose No Risk
This article was originally published in The Tan Sheet
Executive Summary
FDA revised its interim safety and risk assessment for the independent presence of melamine or any one of its analogs in infant formula, saying any amount of one such substance below 1 part per million does not raise public health concerns
You may also be interested in...
Mead Johnson Looks City To City In Chinese Expansion Strategy
A disciplined growth strategy enables Mead Johnson Nutrition to expand its footprint in China and other emerging markets, as lower U.S. birth rates continue to dampen the firm's domestic business
Mead Johnson Looks City To City In Chinese Expansion Strategy
A disciplined growth strategy enables Mead Johnson Nutrition to expand its footprint in China and other emerging markets, as lower U.S. birth rates continue to dampen the firm's domestic business.
Mead Johnson Looks City To City In Chinese Expansion Strategy
A disciplined growth strategy enables Mead Johnson Nutrition to expand its footprint in China and other emerging markets, as lower U.S. birth rates continue to dampen the firm's domestic business.